Plant Extracts and Phytochemicals, a Promising Strategy Against Oral Lichen Planus: A Review on Clinical Trials

被引:3
作者
Gupta S. [1 ]
Nath L.R. [1 ]
Mangalathillam S. [1 ]
机构
[1] Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Ponekkara P.O, Kerala, Kochi
关键词
autoimmune; clinical trials; COVID-19; INF-γ; Oral lichen planus; phytochemicals;
D O I
10.2174/1872208316666220718145421
中图分类号
学科分类号
摘要
Background: Oral lichen planus (OLP) is an autoimmune disease that distress keratinized cells of the oral epithelium. Topical corticosteroids and other potential thera-pies like immunosuppressives, hydroxychloroquine, azathioprine, mycophenolate, dap-sone, retinoids, biologic agents are used for the management of OLP. However, their effec-tiveness, best dose, duration of treatment and safety remain mostly unidentified. Moreover, recurrence of disease and dose-related side effects are the other issues. Objective: The primary objective of the review is to explore the existing clinical trials for the efficacy of phytochemicals in treating OLP in comparison to corticosteroids. A com-prehensive information about their mode of action is also discussed. Methods: We have discussed different clinical trials conducted on various phytochemicals and plant extracts/formulations like curcumin, lycopene, quercetin, glycyrrhizin, purslane, raspberry, aloe vera gel and aloe vera mouthwash for the treatment of OLP. Results: The current therapy for the management of OLP has numerous adverse effects and requires a long-term treatment. Phytochemicals can be a very good alternative in overcom-ing these side effects and reducing the course of treatment. Conclusion: Herbal extracts and their formulations can be an effective alternative to the current therapy due to their proven therapeutic effects, reduced side effects, long-term ap-plicability, prevention of recurrence as well as progression into cancer. © 2023 Bentham Science Publishers.
引用
收藏
页码:80 / 91
页数:11
相关论文
共 87 条
  • [21] Fitzpatrick SG, Hirsch SA, Gordon SC., The malignant transformation of oral lichen planus and oral li-chenoid lesions: A systematic review, J Am Dent As-soc, 145, 1, pp. 45-56, (2014)
  • [22] Gonzalez-Moles MA, Scully C, Gil-Montoya JA., Oral lichen planus: Controversies surrounding malignant transformation, Oral Dis, 14, 3, pp. 229-243, (2008)
  • [23] Larsson A, Warfvinge G., Malignant transformation of oral lichen planus, Oral Oncol, 39, 6, pp. 630-631, (2003)
  • [24] Mattsson U, Jontell M, Holmstrup P., Oral lichen planus and malignant transformation: Is a recall of patients justified?, Crit Rev Oral Biol Med, 13, 5, pp. 390-396, (2002)
  • [25] van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I., A review of the recent literature regarding malignant transformation of oral lichen planus, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 88, 3, pp. 307-310, (1999)
  • [26] Hertel M, Schmidt-Westhausen AM, Wendy S, Et al., Onset of oral lichenoid lesions and oral lichen planus following COVID-19 vaccination: A retrospective analysis of about 300,000 vaccinated patients, Vac-cines, 10, 3, (2022)
  • [27] Rasul TF, Anderson J, Bergholz DR, Faiz A, Prasad RR., Gold dental implant-induced oral lichen planus, Cureus, 14, 2, (2022)
  • [28] Lurya E, Evdaev A., Herbal composition useful for treatment or oral cavity and a method for its local de-livery thereof, (2001)
  • [29] Najafi S, Sahebjamee M, Amanlou M., Treatment of oral lichen planus with a combination of triamcino-lone and retinoic acid, (2014)
  • [30] Lavanya N, Jayanthi P, Rao UK, Ranganathan K., Oral lichen planus: An update on pathogenesis and treatment, J Oral Maxillofac Pathol, 15, 2, pp. 127-132, (2011)